News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension in Hot Line Session at ESC Congress 2024
Monday, September 02, 2024George Medicines a latestage biopharmaceutical company addressing significant unmet need in the treatment of cardiometabolic disease today announced the presentation of results from its two pivotal Phase III trials at a Hot Line session of the Europe...
BridgeBio Shares Data on Serum TTR Increase When Switching Participants from Placebo and Tafamidis to Acoramidis in ATTRibute-CM and its Open-Label Extension
Monday, September 02, 2024BridgeBio Pharma Inc a commercialstage biopharmaceutical company focused on genetic diseases presented additional data from an analysis of its Phase ATTRibuteCM and openlabel extension study of acoramidis in ATTRCM at the European Society of Cardiol...
Sanyou Bio Launches Comprehensive Monkeypox Product Line
Saturday, August 31, 2024Sanyou Biopharmaceuticals Shanghai Co Ltd announced the launch of a comprehensive product line targeting monkeypox which includes antigens monoclonal antibodies and overexpression cell lines This product line features items across three main categor...
Adaptive Announces IVDR Certification for clonoSEQ® in the European Union
Friday, August 30, 2024Adaptive Biotechnologies Corporation a commercialstage biotechnology company focused on translating the genetics of the adaptive immune system into clinical products for diagnosing and treating diseases today announced that its clonoSEQ
SciSparc and Clearmind Medicine Collaboration Results in Publication of Application for Innovative Ketamine-Based Combination
Friday, August 30, 2024SciSparc Ltd a clinicalstage specialty pharmaceutical company focused on developing therapies for central nervous system disorders and rare diseases announced today that its ongoing collaboration with Clearmind Medicine Inc
QIAGEN extends QIAstat-Dx's reach into precision medicine with a new partnership for companion diagnostics in chronic diseases
Thursday, August 29, 2024QIAGEN has announced the expansion of its Master Collaboration Agreement with AstraZeneca to develop and commercialize companion diagnostics CDx for AstraZenecas upcoming therapies targeting chronic diseases
Protect Pharmaceutical Corp. (PRTT) Completes Merger with KARINCA Logistics
Thursday, August 29, 2024Protect Pharmaceutical Corp announces it completed the necessary documentation to finalize the merger with KARINCA Logistics wwwkarincalogisticscom PRTTs Management believes that the KARINCA Logistics merger should add substantial
Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration
Wednesday, August 28, 2024Addex Therapeutics a clinicalstage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders and Indivior PLC today announced the selection of clinical candidates from their G...
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease
Wednesday, August 28, 2024OKYO Pharma Limited a clinicalstage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease DED a multibilliondollar market and anterior ocular segment diseases including neuropathic corneal...
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study
Tuesday, August 27, 2024Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis HOA The results showed there is no evidence of excess cardiovascular risk and no statistically significant difference in major adverse cardiovascular event...
